Treatment
Zuberitamab clinical trials
We’re tracking 2 recruiting studies that include Zuberitamab, each written for real people, not researchers, below.
Recruiting studies
- NCT07257510Recruiting
Pomalidomide plus two other drugs for untreated Mantle Cell Lymphoma
This trial tests a combination of three drugs (pomalidomide, orelabrutinib, and zuberitamab) in people with Mantle Cell Lymphoma who have not yet received treatment. It aims to see if this combination works better than standard therapy, especially for those with high-risk features.
Beijing, Beijing MunicipalityAges 18–80 - NCT06985472RecruitingPhase 2
Orelabrutinib and Zuberitamab for newly treated MZL
This trial tests a combination of two targeted drugs, orelabrutinib and zuberitamab, as a first treatment for marginal zone lymphoma (MZL). It aims to see if this combination works well for patients who have not had systemic therapy before.
Guangzhou, GuangdongAges 18 years+
Common questions
- Are there clinical trials studying Zuberitamab?
- Yes. Clin2 currently lists 2 recruiting studies that include Zuberitamab, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Zuberitamab trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Zuberitamab an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Zuberitamab or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.